Agios Pharmaceuticals | 8-K:重大事件
Agios Pharmaceuticals | 10-Q:季度報表
Agios Pharmaceuticals | 8-K:Agios報告業務亮點和2024年第一季度財務業績
Agios Pharmaceuticals | ARS:年度報告
Agios Pharmaceuticals | DEFA14A:其他
Agios Pharmaceuticals | DEF 14A:股東委託書決議
Agios Pharmaceuticals | 4:持股變動聲明-董事 FOUSE JACQUALYN A
Agios Pharmaceuticals | 4:持股變動聲明-董事 Foster-Cheek Kaye I
Agios Pharmaceuticals | 4:持股變動聲明-董事 Foster-Cheek Kaye I
Agios Pharmaceuticals | 4:持股變動聲明-高管 Washburn Theodore James Jr.
Agios Pharmaceuticals | 144:擬議出售證券
Agios Pharmaceuticals | 144:擬議出售證券
Agios Pharmaceuticals | 144:擬議出售證券
Agios Pharmaceuticals | 4:持股變動聲明-高管 Gheuens Sarah
Agios Pharmaceuticals | 4:持股變動聲明-高管 Jones Cecilia
Agios Pharmaceuticals | 4:持股變動聲明-高管 Washburn Theodore James Jr.
Agios Pharmaceuticals | 4:持股變動聲明-高管 Goff Brian
Agios Pharmaceuticals | 4:持股變動聲明-高管 Burns James William
Agios Pharmaceuticals | 4:持股變動聲明-高管 Milanova Tsveta
Agios Pharmaceuticals | 144:擬議出售證券
暫無數據